Substance use disorder: Epidemiology, medical consequences and treatment

被引:5
作者
Fuster, Daniel [1 ]
Zuluaga, Paola [1 ]
Muga, Robert [1 ]
机构
[1] Hosp Univ Germans Trias I Pujol, Univ Autonoma Barcelona, Serv Med Interna, Unidad Adicc, Badalona, Barcelona, Spain
来源
MEDICINA CLINICA | 2024年 / 162卷 / 09期
关键词
Substance use disorder; Alcohol; Opiates; Cocaine; Cannabis; Benzodiazepines; Epidemiology; Medical consequences; Treatment; MARIJUANA SMOKING; ALCOHOL-USE; COCAINE; DRUG; IMPACT; LIVER; COMPLICATIONS; CARE;
D O I
10.1016/j.medcli.2023.11.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substance use is a common health problem, and substance use disorder, which is its most severe presentation, is associated with multiple medical consequences and a negative impact on individual and on population health. Substance use disorder needs to be addressed as any chronic medical condition; therefore, it has to be detected at the early stages and has to be properly treated to prevent drug-related harm. Internists should be able to recognize and treat intoxication and abstinence. Internists should also be able to refer the patient to state of the art long term treatment, aimed to detoxification and treatment induction to promote abstinence and prevent relapse. In this narrative review we will discuss substance use epidemiology, its main medical consequences and its treatment, with a focus on alcohol, opiates, cocaine and other stimulants, cannabis and benzodiazepines.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 60 条
  • [1] Agencia Espanola de medicamentos y productos sanitarios. Ministerio de Sanidas Servicios Sociales e Igualdad, 2017, Utilizacion de medicamentos opioides en Espana durante el periodo 2008-2015
  • [2] American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU
  • [3] Alcoholic and Cocaine-Associated Cardiomyopathies
    Awtry, Eric H.
    Philippides, George J.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 52 (04) : 289 - 299
  • [4] Why do we focus on the exception and not the rule? Examining the prevalence of mono- versus polysubstance use in the general population
    Bailey, Allen J.
    McHugh, R. Kathryn
    [J]. ADDICTION, 2023, 118 (10) : 2026 - 2029
  • [5] Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity
    Baldo, Brian A.
    [J]. ARCHIVES OF TOXICOLOGY, 2021, 95 (08) : 2627 - 2642
  • [6] Cabezas Joaquin, 2016, Clin Liver Dis (Hoboken), V8, P59, DOI 10.1002/cld.571
  • [7] Psychiatric comorbidities in alcohol use disorder
    Castillo-Carniglia, Alvaro
    Keyes, Katherine M.
    Hasin, Deborah S.
    Cerda, Magdalena
    [J]. LANCET PSYCHIATRY, 2019, 6 (12): : 1068 - 1080
  • [8] Centers for Disease Control and Prevention (CDC), 2017, Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI). Average for United States 2006-2010 Alcohol-Attributable Deaths Due to Excessive Alcohol Use
  • [9] Neurotoxicity of MDMA: Main effects and mechanisms
    Costa, Giulia
    Golembiowska, Krystyna
    [J]. EXPERIMENTAL NEUROLOGY, 2022, 347
  • [10] Delegacion del Gobierno para el Plan Nacional sobre Drogas O. Monografia, Alcohol 2021: Consumo y consecuencias